METTL3 and neoplasm: Yin and colleagues128 determined that METTL3 deficiency impairs SPRED2 translation mediated by YTHDF1, activating NF‐κB and STAT3 signalling, which boosts tumour‐associated M1/M2‐like macrophages and regulatory T‐cell infiltration.